| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 25, 2024 | Nov 26, 2024 | Aptose Biosciences Inc. | CEO | Buy | 91.3 | +100,000 | 19.48% | ✗ | $20K |
| Sep 19, 2022 | Sep 21, 2022 | Aptose Biosciences Inc. | CEO | Buy | 82.5 | +10,000 | 2.83% | ✗ | $6.8K |
| Jun 6, 2022 | Jun 6, 2022 | Aptose Biosciences Inc. | CEO | Buy | 82.5 | +10,000 | 2.91% | ✗ | $9.7K |
| Dec 16, 2021 | Dec 17, 2021 | Aptose Biosciences Inc. | CEO | Buy | 83.8 | +13,183 | 3.99% | ✗ | $20K |
| Dec 15, 2021 | Dec 15, 2021 | Aptose Biosciences Inc. | CEO | Buy | 86.3 | +17,822 | 5.71% | ✗ | $20K |
| Nov 26, 2021 | Nov 29, 2021 | Aptose Biosciences Inc. | CEO | Buy | 83.8 | +8,643 | 2.85% | ✗ | $20K |
| Jul 2, 2021 | Jul 6, 2021 | Aptose Biosciences Inc. | CEO | Buy | 78.8 | +6,081 | 2.04% | ✗ | $20K |
| Jul 10, 2020 | Jul 10, 2020 | Aptose Biosciences Inc. | CEO | Sell | 37.5 | -168,891 | -36.21% | ✗ | $1M |
| Mar 25, 2020 | Mar 26, 2020 | Aptose Biosciences Inc. | CEO | Buy | 68.8 | +3,400 | 0.73% | ✗ | $19.8K |
| Oct 24, 2019 | Oct 28, 2019 | Aptose Biosciences Inc. | CEO | Buy | 86.3 | +10,000 | 6.54% | ✗ | $19.2K |
| Apr 18, 2019 | Apr 19, 2019 | Aptose Biosciences Inc. | CEO | Buy | 86.3 | +10,000 | 6.99% | ✗ | $18.5K |
| Mar 14, 2019 | Mar 15, 2019 | Aptose Biosciences Inc. | CEO | Buy | 86.3 | +10,000 | 7.52% | ✗ | $19K |